Publications
117
Citations
7,205
Est. group size
~30
Recurring co-author estimate
Active years
40
Publishing since 1987
Rama K. Mallampalli's research focuses on lung diseases, particularly how cells in the lungs respond to injury, infection, and inflammation at the molecular level. Work spans topics like protein degradation pathways, cell death mechanisms (including a form called ferroptosis), pulmonary hypertension, acute respiratory distress syndrome, and effects of substances like cigarette smoke and vaping on lung tissue. The lab also explores potential drug targets and biomarkers relevant to critical care and chronic lung conditions.
Publication output has grown substantially over the last decade, rising from occasional output in 2017-2018 to a sustained high volume of 7-16 papers per year since 2019, with a recent peak in 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Hippo to the rescue? Advancing technologies in <i>ex vivo</i> lung perfusion
American Journal of Respiratory Cell and Molecular Biology · 2025
- Abstract 4365999: Knockout of the cytosolic RNA receptor melanoma differentiation-associated protein 5 reduces pulmonary hypertension
Circulation · 2025
- Neutrophils and galectin-3 defend mice from lethal bacterial infection and humans from acute respiratory failure
Nature Communications · 2024
- Oxidized phospholipid and transcriptomic signatures of THC-related vaping associated lung injury
Scientific Reports · 2024
- Loss of the Cytosolic Double Stranded RNA Receptor MDA5 Contributes to Pulmonary Artery Endothelial Cell Dysfunction
2024
- Discovering selective antiferroptotic inhibitors of the 15LOX/PEBP1 complex noninterfering with biosynthesis of lipid mediators
Proceedings of the National Academy of Sciences · 2023
- Serum metabolomic signatures of fatty acid oxidation defects differentiate host-response subphenotypes of acute respiratory distress syndrome
Respiratory Research · 2023
- Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society Report
Annals of the American Thoracic Society · 2023
- A new thiol-independent mechanism of epithelial host defense against Pseudomonas aeruginosa: iNOS/NO• sabotage of theft-ferroptosis
Redox Biology · 2021
- A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance
Nature Chemical Biology · 2021
- Transcriptional and Proteomic Characterization of Telomere-Induced Senescence in a Human Alveolar Epithelial Cell Line
Frontiers in Medicine · 2021
- Endotoxin stabilizes protein arginine methyltransferase 4 (PRMT4) protein triggering death of lung epithelia
Cell Death and Disease · 2021
- Update in Critical Care 2019
American Journal of Respiratory and Critical Care Medicine · 2020
- Chemical Inhibition of PTEN‐Induced Kinase 1 (PINK1) Degradation Confers Neuroprotection in Culture Models of Parkinson’s Disease
The FASEB Journal · 2020
- PULMONARY HYALINIZING GRANULOMAS: AN AGGRESSIVE CLINICAL COURSE
CHEST Journal · 2020
- bioRxiv (Cold Spring Harbor Laboratory)×6
- American Journal of Respiratory and Critical Care Medicine×4
- Journal of Biological Chemistry×3
- American Journal of Respiratory Cell and Molecular Biology×3
- Nature Chemical Biology×2
- Sarah E. Bauer
Medicine · Indiana University
- Howard Eigen
Medicine · Indiana University
- George El-Ferzli
Medicine · The Ohio State University
- Robert S. Tepper
Medicine · Indiana University
- L. Frank
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile